Journal Article

Clinical Trial End Points for Hemodialysis Vascular Access

  • Shenoy S
  • Allon M
  • Beathard G
  • et al.
Clinical Journal of the American Society of Nephrology (2018) 13(3) 490-494
DOI: 10.2215/cjn.13321216
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hemodialysis vascular access is the “lifeline” for patients on hemodialysis. Unfortunately, because of its poor patency and significant complication rate, it is also the “Achilles heel” of hemodialysis. For example, the current unassisted arteriovenous fistula (AVF) maturation rate is only

Cite

CITATION STYLE

APA

Shenoy, S., Allon, M., Beathard, G., Brouwer-Maier, D., Dember, L. M., Glickman, M., … Wasse, H. (2018). Clinical Trial End Points for Hemodialysis Vascular Access. Clinical Journal of the American Society of Nephrology, 13(3), 490–494. https://doi.org/10.2215/cjn.13321216

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free